ClinVar Miner

Submissions for variant NM_004595.5(SMS):c.388C>T (p.Arg130Cys)

dbSNP: rs1602210346
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Institute for Genomic Medicine, Nationwide Children's Hospital RCV001007564 SCV001468506 pathogenic Syndromic X-linked intellectual disability Snyder type 2021-01-07 criteria provided, single submitter research The c.388C>T (p.Arg130Cys) variant was identified by research whole-genome sequencing of a family trio. It is hemizygous in the male proband, and its de novo status was confirmed by Sanger sequencing. This variant is absent from the gnomAD database, and is predicted to cause a missense change that is damaging according to 20 of 22 in silico tools. The same de novo mutation was reported by Abela et al (PMID: 26174906) in male twins with SMS whose metabolic profiling revealed significant changes in spermine/spermidine pathway metabolites. Notably, the authors observed significantly elevated levels of the metabolic product of spermine synthase (N8-acetylspermidine) compared to controls. Deep targeted resequencing in our trio revealed that the mother is a ~3% mosaic for this variant. We interpret the variant as pathogenic.
GeneReviews RCV001007564 SCV001167183 not provided Syndromic X-linked intellectual disability Snyder type no assertion provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.